[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[S. 2158 Introduced in Senate (IS)]







108th CONGRESS
  2d Session
                                S. 2158

   To amend the Public Health Service Act to increase the supply of 
    pancreatic islet cells for research, and to provide for better 
     coordination of Federal efforts and information on islet cell 
                            transplantation.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             March 2, 2004

 Ms. Collins (for herself, Mrs. Murray, Mr. Warner, Mr. Bingaman, Mr. 
Allen, Mr. Feingold, Mr. Cochran, Mr. Lautenberg, Mr. Hagel, Mr. Reed, 
 Mr. Smith, Mr. Ensign, and Mr. DeWine) introduced the following bill; 
     which was read twice and referred to the Committee on Health, 
                     Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
   To amend the Public Health Service Act to increase the supply of 
    pancreatic islet cells for research, and to provide for better 
     coordination of Federal efforts and information on islet cell 
                            transplantation.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Pancreatic Islet Cell 
Transplantation Act of 2004''.

SEC. 2. ORGAN PROCUREMENT ORGANIZATION CERTIFICATION.

    Section 371 of the Public Health Service Act (42 U.S.C. 273) is 
amended by adding at the end the following:
    ``(c) Pancreases procured by an organ procurement organization and 
used for islet cell transplantation or research shall be counted for 
purposes of certification or recertification under subsection (b).''.

SEC. 3. ANNUAL ASSESSMENT ON PANCREATIC ISLET CELL TRANSPLANTATION.

    Section 429 of the Public Health Service Act (42 U.S.C. 285c-3) is 
amended by adding at the end the following:
    ``(d) In each annual report prepared by the Diabetes Mellitus 
Interagency Coordinating Committee pursuant to subsection (c), the 
Committee shall include an assessment of the Federal activities and 
programs related to pancreatic islet cell transplantation. Such 
assessment shall, at a minimum, address the following:
            ``(1) The adequacy of Federal funding for taking advantage 
        of scientific opportunities relating to pancreatic islet cell 
        transplantation.
            ``(2) Current policies and regulations affecting the supply 
        of pancreata for islet cell transplantation.
            ``(3) The effect of xenotransplantation on advancing 
        pancreatic islet cell transplantation.
            ``(4) The effect of United Network for Organ Sharing 
        policies regarding pancreas retrieval and islet cell 
        transplantation.
            ``(5) The existing mechanisms to collect and coordinate 
        outcomes data from existing islet cell transplantation trials.
            ``(6) Implementation of multiagency clinical investigations 
        of pancreatic islet cell transplantation.
            ``(7) Recommendations for such legislation and 
        administrative actions as the Committee considers appropriate 
        to increase the supply of pancreases available for islet cell 
        transplantation.''.
                                 <all>